Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

All domains that have had their Detailed Research Plan approved have been given access to the data. As of May 2019, 38 GeCIP domains have been granted access to the data, guided by the order of approval of their detailed research plans. These are:

Rare disease

  • Neurology
  • Endocrine and metabolism

  • Hearing and sight
  • Inherited cancer predisposition
  • Renal
  • Cardiovascular
  • Immune disorders
  • Non-malignant haematological and haemostasis disorders
  • Musculoskeletal
  • Respiratory
  • Paediatrics
  • Skin

Cancer

  • Colorectal cancer
  • Breast cancer
  • Lung cancer
  • Ovarian cancer
  • Prostate cancer
  • Cancer of unknown primary
  • Glioma
  • Haematological malignancy
  • Melanoma
  • Pan-cancer
  • Renal cell carcinoma
  • Sarcoma
  • Testicular cancer
  • Upper gastrointestinal cancer
  • Neuroendocrine tumours
  • Head and neck cancer
  • Childhood solid cancers

Cross-cutting

  • Quantitative methods, machine learning and functional genomics
  • Electronic health records

  • Stratified medicine

  • Population genomics

  • Functional effects

  • Functional crosscutting

  • Health economics
  • Enhanced interpretation
  • Ethics and social science

When happens when I get access to the data?

...